Venture Round - Antidote.me

Venture Round - Antidote.me

Investment Firm

Overview

Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.

Announced Date

Sep 07, 2017

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

3

Investor Name
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorSmedvig Ventures
Participant InvestorOctopus Ventures

Round Details and Background

Antidote.me raised $11000000 on 2017-09-07 in Venture Round

Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 14, 2016
Venture Round - Antidote.me
1-undefined
Feb 05, 2015
Series B - Antidote.me
3-13.5M
May 08, 2013
Series A - Antidote.me
2-3.2M
Oct 28, 2011
Venture Round - Antidote.me
1-1.2M

Recent Activity

There is no recent news or activity for this profile.